← 產業報告目錄

Metered Dose Inhalers Market Research Report Information By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Market Forecast Till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-11-21頁數 151報告編號 MRFRHC26937CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Metered Dose Inhalers Market Research Report Information By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Market Forecast Till 2032 Market Overview In 2023, the metered dose inhalers market was estimated to be worth USD 15.8 billion. The market is expected to expand from USD 17.1 billion in 2024 to USD 30.0 billion by 2032, with a compound annual growth rate (CAGR) of 6.43% for the forecast period (2024-2032). The global metered-dose inhaler market is developing due to rising respiratory illness prevalence, increased product releases by industry participants, and greater awareness and education. The increasing availability of innovative metered dosage inhaler (MDI) products is a significant driver of growth in the worldwide MDI industry. These launches result in technology breakthroughs such as better drug delivery systems and ergonomic designs that cater to patient preferences for ease of use and adherence. Novel formulations and combinations provide more therapeutic choices for several respiratory disorders, thereby enhancing therapy efficacy and patient outcomes. Competitive dynamics among pharmaceutical companies stimulate innovation and cost, giving healthcare professionals and consumers access to a broader selection of high-quality MDI options. Furthermore, strategic market expansion into new geographies and focused solutions for specific patient populations fuel market growth, making MDI products essential in the global management of respiratory disorders. Market Segment insights The Metered Dose Inhalers Market is divided into two product categories: press metered dose inhalers and breath-actuated metered dose inhalers. The Metered Dose Inhalers Market is divided into three segments based on propellant type: HFA-134a, HFA-227ea, and HFA-152a. The Metered Dose Inhalers Market has been divided into two segments based on technology: pulmonary and nasal platform technologies. According to indication, the Metered Dose Inhalers Market is divided into Asthma, COPD, and others. The Metered Dose Inhalers Market is divided into three distribution channels: hospital pharmacies, retail pharmacies, and online pharmacies. Regional insights North America held the biggest market share in 2023. However, Asia-Pacific is expected to develop at the fastest CAGR throughout the forecast period (2024-2032). The North American Metered Dose Inhalers market is expanding rapidly, owing to technical improvements, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is being driven by advanced healthcare infrastructure and significant expenditure in research and development, which has enabled the development of cutting-edge Metered Dose Inhalers. The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Metered Dose Inhalers market in Europe is characterized by rising healthcare spending and a well-developed healthcare infrastructure. Asia-Pacific is likely to grow significantly, becoming the fastest growing region throughout the forecast period, with substantial growth driven by a number of major factors. Rapidly expanding healthcare infrastructure and increased investment in healthcare infrastructure in nations such as China, India, and Japan are driving demand for sophisticated inhalers. Major Players AstraZeneca (UK), GSK PLC (UK), Organon (US), Cipla, Inc. (India), Lupin Pharmaceuticals, Inc. (India), Zydus Group (India), Teva Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (US), Aristopharma Ltd. (Bangladesh), and Beximco Pharmaceuticals Limited (Bangladesh) are among the key players in the Metered Dose Inhalers Market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 3.2 DATA FLOW 3.2.1 DATA MINING PROCESS 3.3 PURCHASED DATABASE: 3.4 SECONDARY SOURCES: 3.4.1 SECONDARY RESEARCH DATA FLOW: 3.5 PRIMARY RESEARCH: 3.5.1 PRIMARY RESEARCH DATA FLOW: 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 3.6.1 REVENUE ANALYSIS APPROACH 3.7 DATA FORECASTING 3.7.1 DATA FORECASTING TYPE 3.8 DATA MODELING 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 3.8.2 DATA MODELING: 3.9 TEAMS AND ANALYST CONTRIBUTION 4 MARKET DYNAMICS 4.1 INTRODUCTION 4.2 DRIVERS 4.2.1 INCREASING PRODUCT LAUNCH BY MARKET PLAYERS 4.2.2 GROWING AWARENESS AND EDUCATION 4.3 RESTRAINTS 4.3.1 VOLUNTARY PRODUCT RECALL FROM MARKET PLAYERS 4.3.2 STRINGENT REGULATORY POLICIES 4.4 OPPORTUNITY 4.4.1 INCREASING INVESTMENT BY PRIVATE AND PUBLIC ORGANIZATION 4.4.2 ONGOING CLINICAL TRIALS ASSOCIATED WITH METERED DOSE INHALER 5 MARKET FACTOR ANALYSIS 5.1 PORTER’S FIVE FORCES MODEL 5.1.1 THREAT OF NEW ENTRANTS 5.1.2 BARGAINING POWER OF SUPPLIERS 5.1.3 THREAT OF SUBSTITUTES 5.1.4 BARGAINING POWER OF BUYERS 5.1.5 INTENSITY OF RIVALRY 5.2 IMPACT OF COVID-19 ON THE GLOBAL METERED DOSE INHALERS MARKET 5.3 KEY TRENDS FOR GLOBAL METERED DOSE INHALERS MARKET 6 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT 6.1 OVERVIEW 6.2 PRESS METERED DOSE INHALERS 6.3 BREATH ACTUATED METERED DOSE INHALERS 7 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE 7.1 OVERVIEW 7.2 HFA 134A 7.3 HFA 227EA 7.4 HFA-152A 8 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY 8.1 OVERVIEW 8.2 PULMONARY PLATFORM TECHNOLOGIES 8.3 NASAL PLATFORM TECHNOLOGIES 9 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION 9.1 OVERVIEW 9.2 ASTHMA 9.3 COPD 9.4 OTHERS 10 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL 10.1 OVERVIEW 10.2 HOSPITAL PHARMACIES 10.3 RETAIL PHARMACIES 10.4 ONLINE PHARMACIES 11 GLOBAL METERED DOSE INHALER MARKET, BY REGION 11.1 OVERVIEW 11.2 NORTH AMERICA 11.2.1 US 11.2.2 CANADA 11.3 EUROPE 11.3.1 GERMANY 11.3.2 FRANCE 11.3.3 UK 11.3.4 ITALY 11.3.5 SPAIN 11.3.6 REST OF EUROPE 11.4 ASIA-PACIFIC 11.4.1 CHINA 11.4.2 INDIA 11.4.3 JAPAN 11.4.4 SOUTH KOREA 11.4.5 AUSTRALIA 11.4.6 REST OF ASIA-PACIFIC 11.5 REST OF THE WORLD 11.5.1 MIDDLE EAST & AFRICA 11.5.2 SOUTH AMERICA 12 COMPETITIVE LANDSCAPE 12.1 INTRODUCTION 12.2 MARKET SHARE ANALYSIS, 2023 12.3 COMPETITOR DASHBOARD 12.4 PUBLIC PLAYERS STOCK SUMMARY 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 12.6.1 PARTNERSHIP 12.6.2 PRODUCT LAUNCH/PRODUCT APPROVAL 13 COMPANY PROFILES 13.1 ASTRAZENECA 13.1.1 COMPANY OVERVIEW 13.1.2 FINANCIAL OVERVIEW 13.1.3 PRODUCTS OFFERED 13.1.4 KEY DEVELOPMENTS 13.1.5 SWOT ANALYSIS 13.1.6 KEY STRATEGIES 13.2 GSK PLC 13.2.1 COMPANY OVERVIEW 13.2.2 FINANCIAL OVERVIEW 13.2.3 PRODUCT OFFERED 13.2.4 KEY DEVELOPMENTS 13.2.5 SWOT ANALYSIS 13.2.6 KEY STRATEGIES 13.3 ORGANON GROUP OF COMPANIES 13.3.1 COMPANY OVERVIEW 13.3.2 FINANCIAL OVERVIEW 13.3.3 PRODUCTS OFFERED 13.3.4 KEY DEVELOPMENTS 13.3.5 KEY STRATEGIES 13.4 CIPLA INC. 13.4.1 COMPANY OVERVIEW 13.4.2 FINANCIAL OVERVIEW 13.4.3 PRODUCTS OFFERED 13.4.4 KEY DEVELOPMENTS 13.4.5 SWOT ANALYSIS 13.4.6 KEY STRATEGIES 13.5 LUPIN PHARMACEUTICALS, INC. 13.5.1 COMPANY OVERVIEW 13.5.2 FINANCIAL OVERVIEW 13.5.3 PRODUCT OFFERED 13.5.4 KEY DEVELOPMENTS 13.5.5 SWOT ANALYSIS 13.5.6 KEY STRATEGIES 13.6 ZYDUS GROUP 13.6.1 COMPANY OVERVIEW 13.6.2 FINANCIAL OVERVIEW 13.6.3 PRODUCTS OFFERED 13.6.4 KEY DEVELOPMENTS 13.6.5 KEY STRATEGIES 13.7 TEVA PHARMACEUTICAL INDUSTRIES LTD. 13.7.1 COMPANY OVERVIEW 13.7.2 FINANCIAL OVERVIEW 13.7.3 PRODUCTS OFFERED 13.7.4 KEY DEVELOPMENTS 13.7.5 SWOT ANALYSIS 13.7.6 KEY STRATEGIES 13.8 VIATRIS INC. 13.8.1 COMPANY OVERVIEW 13.8.2 FINANCIAL OVERVIEW 13.8.3 PRODUCTS OFFERED 13.8.4 KEY DEVELOPMENTS 13.8.5 SWOT ANALYSIS 13.8.6 KEY STRATEGIES 13.9 ARISTOPHARMA LTD. 13.9.1 COMPANY OVERVIEW 13.9.2 FINANCIAL OVERVIEW 13.9.3 PRODUCT OFFERED 13.9.4 KEY DEVELOPMENTS SOURCE: ANNUAL REPORT AND PRESS RELEASES 13.9.5 KEY STRATEGIES 13.10 BEXIMCO PHARMACEUTICALS LTD. 13.10.1 COMPANY OVERVIEW 13.10.2 FINANCIAL OVERVIEW 13.10.3 PRODUCTS OFFERED 13.10.4 KEY DEVELOPMENTS 13.10.5 KEY STRATEGIES 13.11 DATA CITATIONS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT TABLE 2 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 3 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 4 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019–2032 (USD MILLION) TABLE 5 GLOBAL METERED DOSE INHALERS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019–2032 (UNITS) TABLE 6 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019–2032 (USD MILLION) TABLE 7 GLOBAL METERED DOSE INHALERS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019–2032 (UNITS) TABLE 8 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019–2032 (USD MILLION) TABLE 9 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2019–2032 (UNITS) TABLE 10 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019–2032 (USD MILLION) TABLE 11 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 134A, BY REGION, 2019–2032 (UNITS) TABLE 12 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019–2032 (USD MILLION) TABLE 13 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA 227EA, BY REGION, 2019–2032 (UNITS) TABLE 14 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019–2032 (USD MILLION) TABLE 15 GLOBAL METERED DOSE INHALERS MARKET, FOR HFA-152A, BY REGION, 2019–2032 (UNITS) TABLE 16 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 17 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 18 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019–2032 (USD MILLION) TABLE 19 GLOBAL METERED DOSE INHALERS MARKET, FOR PULMONARY PLATFORM TECHNOLOGIES, BY REGION, 2019–2032 (UNITS) TABLE 20 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019–2032 (USD MILLION) TABLE 21 GLOBAL METERED DOSE INHALERS MARKET, FOR NASAL PLATFORM TECHNOLOGIES, BY REGION, 2019–2032 (UNITS) TABLE 22 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 23 GLOBAL METERED DOSE INHALERS MARKET, FOR ASTHMA, BY REGION, 2019–2032 (USD MILLION) TABLE 24 GLOBAL METERED DOSE INHALERS MARKET, FOR COPD, BY REGION, 2019–2032 (USD MILLION) TABLE 25 GLOBAL METERED DOSE INHALERS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) TABLE 26 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 27 GLOBAL METERED DOSE INHALERS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2032 (USD MILLION) TABLE 28 GLOBAL METERED DOSE INHALERS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2032 (USD MILLION) TABLE 29 GLOBAL METERED DOSE INHALERS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019–2032 (USD MILLION) TABLE 30 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2019–2032 (USD MILLION) TABLE 31 NORTH AMERICA: METERED DOSE INHALER MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 32 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 33 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 34 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 35 NORTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 36 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 37 NORTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 38 NORTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 39 NORTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 40 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 41 US: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 42 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 43 US: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 44 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 45 US: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 46 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 47 US: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 48 US: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 49 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 50 CANADA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 51 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 52 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 53 CANADA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 54 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 55 CANADA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 56 CANADA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 57 CANADA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 58 EUROPE: METERED DOSE INHALER MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 59 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 60 EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 61 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 62 EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 63 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 64 EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 65 EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 66 EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 67 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 68 GERMANY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 69 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 70 GERMANY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 71 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 72 GERMANY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 73 GERMANY: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 74 GERMANY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 75 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 76 FRANCE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 77 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 78 FRANCE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 79 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 80 FRANCE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 81 FRANCE: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 82 FRANCE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 83 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 84 UK: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 85 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 86 UK: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 87 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 88 UK: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 89 UK: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 90 UK: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 91 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 92 ITALY: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 93 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 94 ITALY: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 95 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 96 ITALY: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 97 ITALY: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 98 ITALY: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 99 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 100 SPAIN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 101 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 102 SPAIN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 103 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 104 SPAIN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 105 SPAIN: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 106 SPAIN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 107 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 108 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 109 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 110 REST OF EUROPE: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 111 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 112 REST OF EUROPE: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 113 REST OF EUROPE: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 114 REST OF EUROPE: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 115 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 116 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 117 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 118 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 119 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 120 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 121 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 122 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 123 ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 124 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 125 CHINA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 126 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 127 CHINA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 128 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 129 CHINA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 130 CHINA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 131 CHINA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 132 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 133 INDIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 134 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 135 INDIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 136 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 137 INDIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 138 INDIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 139 INDIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 140 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 141 JAPAN: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 142 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 143 JAPAN: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 144 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 145 JAPAN: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 146 JAPAN: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 147 JAPAN: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 148 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 149 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 150 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 151 SOUTH KOREA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 152 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 153 SOUTH KOREA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 154 SOUTH KOREA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 155 SOUTH KOREA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 156 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 157 AUSTRALIA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 158 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 159 AUSTRALIA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 160 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 161 AUSTRALIA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 162 AUSTRALIA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 163 AUSTRALIA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 164 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 165 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 166 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 167 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 168 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 169 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 170 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 171 REST OF ASIA-PACIFIC: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 172 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 173 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 174 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 175 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 176 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 177 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 178 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 179 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 180 REST OF THE WORLD: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 181 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 182 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 183 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 184 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 185 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 186 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 187 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 188 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 189 MIDDLE EAST & AFRICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 190 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (USD MILLION) TABLE 191 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PRODUCT, 2019–2032 (UNITS) TABLE 192 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (USD MILLION) TABLE 193 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY PROPELLENT TYPE, 2019–2032 (UNITS) TABLE 194 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) TABLE 195 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY TECHNOLOGY, 2019–2032 (UNITS) TABLE 196 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY INDICATION, 2019–2032 (USD MILLION) TABLE 197 SOUTH AMERICA: METERED DOSE INHALER MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD MILLION) TABLE 198 PUBLIC PLAYERS STOCK SUMMARY TABLE 199 PARTNERSHIP TABLE 200 PRODUCT LAUNCH/PRODUCT APPROVAL TABLE 201 ASTRAZENECA: PRODUCT OFFERED TABLE 202 ASTRAZENECA: KEY DEVELOPMENTS TABLE 203 GSK PLC: PRODUCTS OFFERED TABLE 204 ORGANON GROUP OF COMPANIES: PRODUCT OFFERED TABLE 205 CIPLA INC.: PRODUCT OFFERED TABLE 206 CIPLA INC.: KEY DEVELOPMENTS TABLE 207 LUPIN PHARMACEUTICALS, INC.: PRODUCTS OFFERED TABLE 208 LUPIN PHARMACEUTICALS, INC.: KEY DEVELOPMENTS TABLE 209 ZYDUS GROUP: PRODUCTS OFFERED TABLE 210 ZYDUS GROUP: KEY DEVELOPMENTS TABLE 211 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED TABLE 212 VIATRIS INC.: PRODUCTS OFFERED TABLE 213 ARISTOPHARMA LTD.: PRODUCTS OFFERED TABLE 214 BEXIMCO PHARMACEUTICALS LTD.: PRODUCTS OFFERED LIST OF FIGURES FIGURE 1 GLOBAL METERED DOSE INHALER MARKET: STRUCTURE FIGURE 2 GLOBAL METERED DOSE INHALERS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL METERED DOSE INHALERS MARKET FIGURE 6 GLOBAL METERED DOSE INHALERS MARKET, PRODUCT, 2023 & 2032 (USD MILLION) FIGURE 7 GLOBAL METERED DOSE INHALERS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION) FIGURE 8 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PRODUCT, 2023 FIGURE 9 GLOBAL METERED DOSE INHALERS MARKET, PROPELLANT TYPE, 2023 & 2032 (USD MILLION) FIGURE 10 GLOBAL METERED DOSE INHALERS MARKET, BY PROPELLANT TYPE, 2023 & 2032 (USD MILLION) FIGURE 11 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY PROPELLANT TYPE, 2023 FIGURE 12 GLOBAL METERED DOSE INHALERS MARKET, TECHNOLOGY, 2023 & 2032 (USD MILLION) FIGURE 13 GLOBAL METERED DOSE INHALERS MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION) FIGURE 14 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY TECHNOLOGY, 2023 FIGURE 15 GLOBAL METERED DOSE INHALERS MARKET, INDICATION, 2023 & 2032 (USD MILLION) FIGURE 16 GLOBAL METERED DOSE INHALERS MARKET, BY INDICATION, 2023 & 2032 (USD MILLION) FIGURE 17 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY INDICATION, 2023 FIGURE 18 GLOBAL METERED DOSE INHALERS MARKET, DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION) FIGURE 19 GLOBAL METERED DOSE INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2023 & 2032 (USD MILLION) FIGURE 20 GLOBAL METERED DOSE INHALERS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2023 FIGURE 21 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2023 & 2032 (USD MILLION) FIGURE 22 GLOBAL METERED DOSE INHALER MARKET SHARE, BY REGION, 2023 (% SHARE) FIGURE 23 NORTH AMERICA MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION) FIGURE 24 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 25 NORTH AMERICA METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%) FIGURE 26 EUROPE MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION) FIGURE 27 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 28 EUROPE METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%) FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION) FIGURE 30 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 31 ASIA-PACIFIC METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%) FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: METERED DOSE INHALERS MARKET, 2019-2032 (USD MILLION) FIGURE 33 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 34 REST OF THE WORLD METERED DOSE INHALER MARKET SHARE, BY COUNTRY, 2023 (%) FIGURE 35 GLOBAL METERED DOSE INHALER MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 FIGURE 36 COMPETITOR DASHBOARD: GLOBAL METERED DOSE INHALER MARKET FIGURE 37 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 38 ASTRAZENECA: SWOT ANALYSIS FIGURE 39 GSK PLC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 40 GSK PLC: SWOT ANALYSIS FIGURE 41 ORGANON GROUP OF COMPANIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 42 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 43 CIPLA INC.: SWOT ANALYSIS FIGURE 44 LUPIN PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 45 LUPIN PHARMACEUTICALS, INC.: SWOT ANALYSIS FIGURE 46 ZYDUS GROUP: FINANCIAL OVERVIEW FIGURE 47 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 48 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS FIGURE 49 VIATRIS INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 50 VIATRIS INC.: SWOT ANALYSIS FIGURE 51 BEXIMCO PHARMACEUTICALS LTD.: FINANCIAL OVERVIEW SNAPSHOT

提及公司

AstraZeneca (UK)GSK PLC. (UK)Organon (US)CiplaInc. (India)Lupin PharmaceuticalsInc. (India)Zydus Group (India)Teva Pharmaceutical Industries Ltd. (Israel)Viatris Inc. (US)Aristopharma Ltd. (Bangladesh)and Beximco Pharmaceuticals Limited (Bangladesh)

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們